To confirm these observations also in an in vivo setting, we characterized the IL-2R and IL-7R profiles of T cells from systemic lupus erythematosus (SLE) patients undergoing IL-2 immunotherapy. The gene discussed is IL2; the disease is systemic lupus erythematosus.